Some of the cutaneous adverse events to amivantamab, which targets both EGFR and MET, can be severe and have atypical presentations, which led to dose reductions in five of six cases.
The Wonderful World of Wellness ozy.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ozy.com Daily Mail and Mail on Sunday newspapers.
Review Eyes Nail Toxicities Related to Targeted Cancer Therapy medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.